MiniMed Group, Inc. Common Stock cash flow to debt ratio of -135.86% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

MiniMed Group, Inc. Common Stock's free cash flow has decreased 692.45% from $-53.00M last year to $-420.00M, signaling decreasing performance

MiniMed Group, Inc. Common Stock's debt to equity ratio is 0.04, which means that the company's assets are healthy financed, signaling financial stability.

MiniMed Group, Inc. Common Stock's debt has increased relative to shareholder equity from 0.00 last year to 0.04 today, signaling weakened financials

MiniMed Group, Inc. Common Stock has a net cash position, so leverage is healthy.

Interest expense is not separately reported in MiniMed Group, Inc. Common Stock's latest filing, so interest coverage cannot be calculated.

MiniMed Group, Inc. Common Stock's profit margin has decreased (136.05%) in the last year from -9.21% to -21.74%, signaling decreasing performance

MiniMed Group, Inc. Common Stock's short-term assets of $1.35B exceed its short-term liabilities of $702.00M

MiniMed Group, Inc. Common Stock's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

MiniMed Group, Inc. Common Stock's return on equity of -14.45%, is lower than 15.00%, indicating bad performance

MiniMed Group, Inc. Common Stock's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

MiniMed Group, Inc. Common Stock has insufficient public price history to evaluate earnings stability.

MiniMed Group, Inc. Common Stock has negative free cash flow, indicating the company is burning cash rather than generating it

MiniMed Group, Inc. Common Stock has negative free cash flow, indicating cash burn

MiniMed Group, Inc. Common Stock's yearly earnings has decreased 32.40% since last year from $-250.00M to $-331.00M, signaling decreasing performance

MiniMed Group, Inc. Common Stock's yearly revenue has increased 14.25% since last year from $2.71B to $3.10B, signaling increasing performance

ROIC -5.28% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

MiniMed Group, Inc. Common Stock's 3-year revenue CAGR of 11.38% is positive, indicating growing revenue over the past 3 years

MiniMed Group, Inc. Common Stock has insufficient public price history to evaluate revenue consistency.

MiniMed Group, Inc. Common Stock has insufficient public price history to evaluate ROE consistency.

MiniMed Group, Inc. Common Stock has insufficient data to evaluate this check.

MiniMed Group, Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MiniMed Group, Inc. Common Stock is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

MiniMed Group, Inc. Common Stock has an EV/EBITDA ratio of 108.64x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

MiniMed Group, Inc. Common Stock has insufficient data to evaluate this check.

MiniMed Group, Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MiniMed Group, Inc. Common Stock has a price-to-book ratio of 1.45x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

MiniMed Group, Inc. Common Stock has a price-to-sales ratio of 2.22x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue